Chemed To Report Third-Quarter 2022 Earnings October 31, Related Conference Call To Be Held On November 1

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2022, on Monday, October 31, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Tuesday, November 1, 2022, to … [Read more…]

Teijin Automotive Technologies’ Teams Get Creative for a Cause

AUBURN HILLS, Mich.–(BUSINESS WIRE)–When the Operations and Health and Safety management teams of Teijin Automotive Technologies gathered in San Antonio, Texas, earlier this month, operational improvement was not the only focus of the gathering. The team also worked together to create wheel spoke guards to be fitted to wheelchairs that would be donated to individuals … [Read more…]

Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology.

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe—AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access. “Rohit brings a wealth of oncology Market Access and Health Economics and Outcomes Research … [Read more…]

Global Human T-Lymphotropic Virus (Value, Volume, ASP) Market Analysis Report 2022: Segments, Trends, Regulatory and Reimbursement Landscape, Procedures, and Forecasts, 2015-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Human T-Lymphotropic Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The report is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of … [Read more…]

Humana Announces Major Expansion of Florida Dental Network, Benefits

In addition to doubling the number of dentists available to its Medicare Advantage members, Humana is introducing extra financial help for those eligible for both Medicare and Medicaid TAMPA, Fla.–(BUSINESS WIRE)–Florida’s largest Medicare Advantage plan by membership Humana Inc. (NYSE: HUM) announced that it is both enhancing its 2023 dental benefits and significantly increasing the … [Read more…]

Orange County Research Institute Enrolling Patients in Anaheim for Clinical Trial of Promising New Investigational Treatment for Alzheimer’s Disease

Individuals with memory problems encouraged to learn more about study ANAHEIM, Calif.–(BUSINESS WIRE)–Orange County Research Institute (OCRI) is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD) in Anaheim. The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of … [Read more…]

The MolinaCares Accord Supports Health Equity for Arab American Communities with $100,000 Grant

DEARBORN, Mich.–(BUSINESS WIRE)–The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Michigan (“Molina”), presented $100,000 to the Arab Community Center for Economic and Social Services (ACCESS) in support of a pilot program addressing social determinants of health (SDOH) for Arab Americans and community residents. The goal of the program is to improve health equity … [Read more…]

Anthem Blue Cross and Blue Shield Expands Wisconsin Health Care Access from Nine to 68 Counties

Dramatic expansion increases choice for Wisconsinites and will greatly help those transitioning due to the expected end of the federal public health emergency MILWAUKEE–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in Wisconsin is creating greater access to affordable health care for tens of thousands Wisconsin consumers seeking coverage through the Wisconsin Health Care Marketplace. Anthem … [Read more…]

Biocytogen to Present Progress of Preclinical and Clinical Assets at BIO-EUROPE 2022

BEIJING–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26 and virtually on November 2-4, 2022. Using advanced proprietary gene-editing technologies, Biocytogen has developed five proprietary fully human antibody discovery platforms: a RenMab™-based monoclonal antibody platform, a RenLite®-based bispecific antibody platform, a bispecific … [Read more…]

Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information about the Infusion Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical … [Read more…]